Results 101 to 110 of about 53,802 (245)

Single-cell heterogeneity in ductal carcinoma in situ of breast.

open access: yes, 2017
Heterogeneous patterns of mutations and RNA expression have been well documented in invasive cancers. However, technological challenges have limited the ability to study heterogeneity of protein expression.
Gerdes, Michael J.   +26 more
core   +1 more source

Supplementary Figure S5 from Whole-Exome Sequencing Analysis of the Progression from Non–Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma

open access: yes, 2020
Supplementary Figure S5 shows BRCA1 loss of heterozygosity in the different foci of synchronously diagnosed ductal carcinoma in situ and invasive ductal carcinoma of no special type in a BRCA1 germline carrier.
David N. Brown (6742649)   +15 more
core   +1 more source

Multicentric Asynchronous Endocrine Mucin‐Producing Sweat Gland Carcinoma and Mucinous Carcinoma of the Skin

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Endocrine mucin‐producing sweat gland carcinoma (EMPSGC) is an adnexal neoplasm which typically occurs on periorbital skin and demonstrates overlapping histopathologic features with primary mucinous carcinoma of the skin (MCS). Herein, we report a patient who developed five distinct lesions of EMPSGC and MCS over an eight‐year period, some of ...
Ikuko Hirai   +5 more
wiley   +1 more source

Merkel Cell Carcinoma With Divergent Differentiation—Or Something Else? A Triphasic Cutaneous Carcinoma With Lineage Plasticity

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine carcinoma that typically arises in sun‐exposed skin of older or immunosuppressed patients. Combined or collision tumors involving MCC and other cutaneous malignancies are uncommon, and tumors exhibiting more than two distinct malignant phenotypes are exceptionally rare.
Zeinab Khalil   +2 more
wiley   +1 more source

Clinicopathological analysis of ductal carcinoma in situ(DCIS) and ductal carcinoma in situ with microinvasion

open access: yes, 2001
의과학사업단/석사[한글]유방의 관상피내암종은 수술적인 치료로 완치를 기대할 수 있는 질환으로 유방촬영술의 발달로 그 빈도가 증가하고 있다. 관상피내암종의 가장 중요한 병리학적 관심의 하나는 국소적 침윤성 병변이 있느냐이다. 국소적으로 침윤성 병변이 발견되면 그 치료가 관상피내암종과 확연히 달라져 국소치료 뿐만 아니라 방사선치료나 액와부 절제술 등이 필수적이라는 것이 일반적이다. 이에 저자는 미세침윤이 없는 관상피내암종과 미세침윤이 동반된 관상피내암종의
김도일
core  

Sítios prinicpais de metátase de carcinoma de mama: análise de acordo com classificação molecular [PDF]

open access: yes, 2009
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Santos, Renata da Silva Almeida
core  

The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ

open access: yes, 2015
An unforeseen consequence of the introduction of mammographic breast screening has been the marked increase in the number of women diagnosed with ductal carcinoma in situ (DCIS) [1,2].
Francis, Adele   +5 more
core   +1 more source

Microinvasive Papillary carcinoma of the breast with mucinous differentiation and high grade ductal carcinoma in situ: A case report study

open access: yesBasic & Clinical Cancer Research, 2018
A 35-year-old woman had a history of left breast mass without pain, discharge or weight loss. Fine needle aspiration noticed papillary carcinoma. Frozen section diagnosis was invasive carcinoma with papillary feature and free marked margin.
Mazaher Ramezani   +5 more
doaj  

S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary This second part of the S3 guideline on the diagnosis and treatment of alopecia areata (AA), presents key recommendations on topical and systemic therapy, quality of life and support services. The first part of the guideline, published separately, covers the definition and content of epidemiology and diagnosis as well as comorbidities, risk and
Ulrike Blume‐Peytavi   +13 more
wiley   +1 more source

World Health Organization classification of tumours of the breast 6th edition 2026

open access: yesHistopathology, EarlyView.
The 6th edition of the World Health Organization Classification of Breast Tumours introduces changes based on recent advances in our understanding of breast biology, developments in diagnostic modalities, identification of specific molecular targets and new treatment regimes.
Cecily Quinn   +47 more
wiley   +1 more source

Home - About - Disclaimer - Privacy